IPCRG

GTranslate

  • Join our Mailing List
  • Contact us
  • Donate

Search

Working locally in primary care and collaborating globally to improve respiratory health

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • RSS
  • Youtube
Search

Search

  • About us
    • Introducing the IPCRG
    • Our people
    • Our network
    • How we're funded
    • Our objectives and achievements
    • Policies, position papers & statements
    • Our journal: Nature Partner Journals Primary Care Respiratory Medicine (npj PCRM)
    • Advocacy
  • News & Events
    • IPCRG Conferences & Events
  • Research
    • Research strategy
    • Research prioritisation
    • Research collaborations
    • Completed research collaborations
    • Publications
    • Boosting research careers
  • Education
    • Education strategy
    • Programmes
    • Audio-visual tools
    • Breaths
    • Spirometry Simplified
  • Clinical Topics
    • Asthma
    • COPD
    • Rhinitis
    • Breathlessness
    • Prevention
    • Diagnosis
    • Management
    • Tobacco dependence
    • Respiratory infections
    • Pulmonary rehabilitation & supported self-management
  • Right Care
    • Asthma Right Care
    • COPD Right Care
    • Rhinitis Right Care
  • Resources
    • Search Resources
    • Desktop Helpers
    • Image gallery
    • IPCRG COVID-19 and respiratory Q&A
    • Resources for pharmacists
    • Resources for clinical teachers
    • Resources for patients and carers
    • Resources in different languages
    • Right Care resources
HomeiQ&A top questions and answers

iQ&A top questions and answers

iQ&A answers have been helping our colleagues during the COVID-19 pandemic. The top 5 answers at the moment are listed below.

1
14 Dec 2021

How effective are the current SARS-CoV-2 vaccines against the Omicron variant?

IPCRG COVID-19 and respiratory Q&A
08 Dec 2021

What is the risk and impact of myocarditis for young adults aged 16 to 18 years following a COVID vaccination?

IPCRG COVID-19 and respiratory Q&A
Originally published 8 Nov 2021, updated 13 Jan 2022

Are new oral anti-COVID-19 drugs effective?

IPCRG COVID-19 and respiratory Q&A
Originally published 8 Mar 2021, most recent update 18 Jan 2022

What medicines are available to treat an acutely unwell person with COVID-19 in the primary care setting to reduce the risk of hospital admission?

IPCRG COVID-19 and respiratory Q&A
03 Jun 2021

Can we safely use nebulisers during the COVID-19 pandemic in the primary care setting, and if so how?

IPCRG COVID-19 and respiratory Q&A

Return to main answer page

Contact us

businessmanager [at] ipcrg [dot] org

The International Primary Care Respiratory Group is a Scottish Charity (SC 035056) and a Scottish Company Limited by guarantee (Scottish Company Number 256268).

Disclaimer
 

Follow us

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • RSS
  • Youtube

Join us

Sign up for our Newsletter

 

Registered office: 4th Floor, 115 George Street, Edinburgh, Scotland, EH2 4JN.

Privacy Policy
 

A Remora website by Manta Ray Media